| Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration V Luga, L Zhang, AM Viloria-Petit, AA Ogunjimi, MR Inanlou, E Chiu, ... Cell 151 (7), 1542-1556, 2012 | 1374 | 2012 |
| Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in … AM Petit, J Rak, MC Hung, P Rockwell, N Goldstein, B Fendly, RS Kerbel The American journal of pathology 151 (6), 1523, 1997 | 1145 | 1997 |
| Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis A Viloria-Petit, T Crombet, S Jothy, D Hicklin, P Bohlen, JM Schlaeppi, ... Cancer research 61 (13), 5090-5101, 2001 | 690 | 2001 |
| Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts J Rak, Y Mitsuhashi, C Sheehan, A Tamir, A Viloria-Petit, J Filmus, ... Cancer research 60 (2), 490-498, 2000 | 333 | 2000 |
| Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches RS Kerbel, J Yu, J Tran, S Man, A Viloria-Petit, G Klement, BL Coomber, ... Cancer and Metastasis Reviews 20, 79-86, 2001 | 329 | 2001 |
| Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner O López-Ocejo, A Viloria-Petit, M Bequet-Romero, D Mukhopadhyay, ... Oncogene 19 (40), 4611-4620, 2000 | 291 | 2000 |
| Versican/PG‐M G3 domain promotes tumor growth and angiogenesis PS Zheng, J Wen, LC Ang, W Sheng, A Viloria‐Petit, Y Wang, Y Wu, ... The FASEB journal 18 (6), 754-756, 2004 | 246 | 2004 |
| ‘Accidental’anti-angiogenic drugs: anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples RS Kerbel, A Viloria-Petit, G Klement, J Rak European journal of cancer 36 (10), 1248-1257, 2000 | 246 | 2000 |
| Antiproliferative, antiangiogenic and proapoptotic activity of h‐R3: A humanized anti‐EGFR antibody T Crombet‐Ramos, J Rak, R Perez, A Viloria‐Petit International journal of cancer 101 (6), 567-575, 2002 | 230 | 2002 |
| Establishing a link between oncogenes and tumor angiogenesis RS Kerbel, A Viloria-Petit, F Okada, J Rak Molecular medicine 4, 286-295, 1998 | 222 | 1998 |
| The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC) B Golding, A Luu, R Jones, AM Viloria-Petit Molecular cancer 17, 1-15, 2018 | 209 | 2018 |
| Strategies for Delaying or Treating In vivo Acquired Resistance to Trastuzumab in Human Breast Cancer Xenografts JM du Manoir, G Francia, S Man, M Mossoba, JA Medin, A Viloria-Petit, ... Clinical Cancer Research 12 (3), 904-916, 2006 | 182 | 2006 |
| Signalling by transforming growth factor beta isoforms in wound healing and tissue regeneration RWD Gilbert, MK Vickaryous, AM Viloria-Petit Journal of developmental biology 4 (2), 21, 2016 | 167 | 2016 |
| A role for the TGFβ-Par6 polarity pathway in breast cancer progression AM Viloria-Petit, L David, JY Jia, T Erdemir, AL Bane, D Pinnaduwage, ... Proceedings of the National Academy of Sciences 106 (33), 14028-14033, 2009 | 163 | 2009 |
| Acquired resistance to EGFR inhibitors: mechanisms and prevention strategies AM Viloria-Petit, RS Kerbel International Journal of Radiation Oncology* Biology* Physics 58 (3), 914-926, 2004 | 118 | 2004 |
| In vitro procoagulant activity induced in endothelial cells by chemotherapy and antiangiogenic drug combinations: modulation by lower-dose chemotherapy L Ma, G Francia, A Viloria-Petit, DJ Hicklin, J du Manoir, J Rak, RS Kerbel Cancer research 65 (12), 5365-5373, 2005 | 102 | 2005 |
| Contrasting effects of VEGF gene disruption in embryonic stem cell‐derived versus oncogene‐induced tumors A Viloria‐Petit, L Miquerol, LY Joanne, M Gertsenstein, C Sheehan, L May, ... The EMBO Journal, 2003 | 89 | 2003 |
| Release of endothelial cell associated VEGFR2 during TGF-β modulated angiogenesis in vitro M Jarad, EA Kuczynski, J Morrison, AM Viloria-Petit, BL Coomber BMC cell biology 18, 1-10, 2017 | 62 | 2017 |
| Characterization of TGFβ signaling during tail regeneration in the leopard Gecko (Eublepharis macularius) RWD Gilbert, MK Vickaryous, AM Viloria‐Petit Developmental Dynamics 242 (7), 886-896, 2013 | 52 | 2013 |
| The TGFβ-Par6 polarity pathway: Linking the Par complex to EMT and breast cancer progression AM Viloria-Petit, JL Wrana Cell Cycle 9 (4), 623-624, 2010 | 50 | 2010 |
